A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis.

Eleonora TavazziNiels BergslandJens KuhleDejan JakimovskiMurali RamanathanAleksandra M MaceskiDavorka TomicJesper HagemeierHarald KropshoferDavid LeppertMichael G DwyerBianca Weinstock-GuttmanRalph H B BenedictRobert Zivadinov

Published in: Journal of neurology (2019)

Atrophied T2-LV is associated with disability accrual in MS, and to several multimodal markers of disease evolution.

Keyphrases

multiple sclerosis
pain management
white matter
magnetic resonance imaging
contrast enhanced
mass spectrometry
ms ms
computed tomography